[1] |
谢代彬,王梅,贾雁平,等.消化性溃疡合并幽门螺杆菌感染患儿奥美拉唑四联疗法治疗效果分析[J].中华医院感染学杂志,2016,26(5):1146-1148.
|
[2] |
Manguso F,Riccio E,de Nucci G,et al.Helicobacter pylori infection in bleeding peptic ulcer patients after non steroidal antiin flammatory drug consumption[J].World J Gastroenterol,2011,17(40):4509-4516.
|
[3] |
汪官富,徐颖鹤,苏杭,等.双歧杆菌四联活菌片联合三联疗法治疗幽门螺杆菌阳性消化性溃疡的疗效[J].中华医院感染学杂志,2013,23(9):2074-2076.
|
[4] |
Mabe K,Takahashi M,Oizumi H,et al.Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?[J].World J Gastroenterol,2009,15(34):4290-4297.
|
[5] |
陈义辉,蔡和利.含呋喃唑酮三、四联疗法根除幽门螺杆菌感染的临床观察[J].海峡药学,2015,27(12):115-117.
|
[6] |
中华医学会消化病学分会幽门螺杆菌学组/全国幽门螺杆菌研究协作组.第四次全国幽门螺杆菌感染处理共识报告[J].中华内科杂志,2012,51(10):832-837.
|
[7] |
于阿利.奥美拉唑四联疗法根除消化性溃疡患者幽门螺杆菌76例[J].中国药业,2015,24(23):181-183.
|
[9] |
于志刚,段志军.康复新液联合雷贝拉唑治疗老年消化性溃疡的疗效[J].中国老年学杂志,2013,33(21):5309-5310.
|
[13] |
李桂水,杨敏京,边连朵,等.四联疗法联合口腔洁治对胃溃疡患者胃幽门螺杆菌根除的临床疗效观察[J].中国现代医学杂志,2016,26(5):140-142.
|
[16] |
陈益忠.雷贝拉唑,莫西沙星,阿莫西林联合治疗幽门螺杆菌阳性消化性溃疡的疗效观察[J].上海医药,2012,33 (1):19-20.
|
[17] |
崔英,沈曼茹,高振军,等.四联疗法和序贯疗法治疗服用非甾体类消炎药人群幽门螺杆菌感染的临床对照研究[J].现代生物医学进展,2015,15(6):1105-1108.
|
[8] |
Wu DC,Hsu PI,Wu JY,et al.Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection[J].Clin Gastroenterol Hepatol,2010,8 (1):36-41.
|
[10] |
Morgan DR,Torres J,Sexton R,et al.Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American Communities[J].JAMA,2013,309(6):578-586.
|
[11] |
Francavilla R,Lionetti E,Castellaneta S,et al.Clarithromycin resistant genotypes and eradication of Helicobacter pylori[J]. J Pediatr,2010,157(2):228-232.
|
[12] |
Mayerle J,den Hoed CM,Schurmann C,et al.Identification of genetic loci associated with Helicobacter pylori serologic status[J].JAMA,2013,309(18):1912-1920.
|
[14] |
Malfertheiner P,Megraud F,O′Morain CA,et al.Management of Helicobacter pylori infection—the Maastricht Ⅳ/ Florence Consensus Report[J].Gut,2012,61(5):646-664.
|
[15] |
Liu KS,Hung IF,Seto WK,et al.Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients:an open label,randomised,crossover trial[J].Gut,2014,63(9):1410-1415.
|
[18] |
臧东方.序贯疗法与四联疗法治疗幽门螺杆菌阳性胃溃疡的临床观察[J].中国处方药,2016,14(1):60-61.
|
[19] |
张海文,邢茂娟.不同幽门螺旋杆菌治疗方法对消化性溃疡的疗效评价[J].中国继续医学教育,2015,7(7):223-224.
|
[20] |
龚家顺,彭惠容,刘芬,等.以莫西沙星为主的三联疗法在幽门螺杆菌感染首次根除失败患者中应用价值[J].胃肠病学和肝病学杂志,2014,23(7):274-279.
|